The field of biotechnology has undergone some of the most sweeping changes in recent times and has had far-reaching impact both on our quality of life and on other areas of technology. Still, the biotechnology sector requires heavy investment that can take a long time to bear fruit. Often only solid industrial property rights that ensure exclusive entitlement to market the resulting products will encourage companies to set out on the path that will eventually lead to market. In view of the special nature of biotechnology inventions in terms of both the requirements for protection and differences in legislation in the different countries, being able to secure the corresponding rights will often depend on obtaining proper advice for selecting subject matter for patenting, drafting and prosecuting patents, and negotiating licences.
ELZABURU has a multidisciplinary team of experienced patent attorneys who specialize in the field of biotechnology and can provide across-the-board advice for both obtaining protection for inventions and negotiating licenses and other business arrangements.
Innovation learning pills: patentar y publicar ¿Es compatible?
The IGTP Innovation Unit organized a session to discuss the key points about patenting without delaying researchers' scientific publications
Encuentro de proveedores del sector sanitario en Castilla y León
Biotechnologist Marina Reig presents ELZABURU's services for the protection of pharmaceutical and sanitary innovations.
IUCT - Master en registro farmacéutico y regulatory affairs : La patentabilidad y Directiva 98/44 relativa a las invenciones biotecnológicas
ELZABURU associate partner Mª Rosa de la Colina gives a lecture about patents and trade secrets in the biotech sector.
IE University - Natural science, technology and business: an opportunity junction
Lecture about technology transfer for biotechnological innovations.
The possibility of patenting human parthenotes. Judgment of the Court of Justice of 18 December 2014, International Stem Cell Corporation (C-364/13)
Commentary of the case C-364/13 on the legal protection of biotechnological inventions and the concept of human embryo
No video content currently available.